First Warning Systems, Inc. (FWS), a
Rush currently serves as president for
"I am so pleased to have this opportunity to work with such an extraordinary team of dedicated (and smart) individuals,” said Rush. “The goal is so exciting - the motivating driver to raise the bar on early detection and thus to save lives - with the appreciated potential of economic success. I could not ask for more positive reasons to say yes to joining in this effort to advance this technology.”
First Warning Systems CEO
“With the addition of Ms. Rush to the board, First Warning Systems will be able to expand our relationship with the breast imaging community,” said Royea. “Her expertise provides a welcome and necessary component toward understanding how the FWS technology enhances current modalities and simultaneously facilitates advancements in screening protocols. With the recent mandate requiring dense breast notification for patients here in the U.S. and an epidemic of breast cancer in
With extensive clinical trials, and years of advanced algorithm refinement completed, FWS' patented intelligent predictive models are projected to improve accuracy for breast cancer assessment to over 75 percent. Unlike mammography and ultrasound which only image tissue characteristics, the FWS system detects tissue alterations down to the cellular level, allowing for earlier, safer, more accurate cancer prediction for women of all ages and tissue types. Ultimately, the FWS system is intended to reduce the number of necessary radiation procedures, while eliminating potentially unnecessary surgeries.
FWS has devoted years of clinical research and significant funding toward the development of a process that promotes a proactive, compassionate, personalized approach to patient wellness and breast health. Designed to fit a wearable garment similar to a sports bra, the company anticipates bringing their technology to market for an affordable price that will make it widely accessible to all markets.
To learn more, visit http://www.firstwarningsystems.com.
About First Warning Systems Process
Dynamic thermal readings of breast tissue cellular changes creates a patented time sequenced profile which correlates to circadian cellular processes expressed through specific circadian genotypes. Multiple bioinformatics algorithms compare the circadian gene expression profiles to identify breast tissue abnormalities at different stages of development of disturbed breast tissue cells. FWS delivers an objective Clinical Decision Support Service report to the primary care physician with industry leading accuracy.
About First Warning Systems
First Warning Systems, (FWS) founded in 2008, is based in
Read the full story at http://www.prweb.com/releases/2013/10/prweb11227168.htm
Most Popular Stories
- US Consumer Borrowing Rose $18.2B in Oct.
- 2014 World Cup Official Noisemakers Quieter than Vuvuzelas
- Unjustified?: Justin Timberlake's Grammy snub
- Economic Bright Spots Not a Sure Boost for President Obama
- Apple Wants Samsung to Pay $22M for Patent Dispute Legal Bills
- North Korea Frees 85-Year-Old Vet Merrill Newman
- NSA Defends Global Cellphone Tracking Legality
- Starbucks Gets Grinchy; No Gingerbread Lattes for Tampa Customers
- Jobs Report Brings Cheer As Unemployment Drops to Five-year Low
- Apple Paid Its Lawyers More Than $60MM to Defeat Samsung in Court